SenesTech Marks Significant Growth in Direct-to-Consumer and Subscription Revenue Following E-Commerce Strategy Shift

SenesTech Achieves Record Growth in Direct-to-Consumer Sales and Subscriptions

SenesTech, Inc. (NASDAQ: SNES), renowned for its innovative approach to managing animal pest populations through humane fertility control solutions, has made headlines with its recent financial results indicating substantial growth in direct-to-consumer sales and subscription revenues. This upward trajectory follows a strategic shift in its e-commerce approach, particularly with a new focus on in-house management of Amazon sales, spearheaded by the newly appointed CEO, Michael Edell.

Q1 2026 Financial Overview

In the first quarter of 2026, SenesTech reported revenues of $493,000, a modest increase of 2% compared to the same period in 2025. Despite experiencing a drop of approximately $157,000 in third-party e-commerce revenue due to its transition from external management to internal control of Amazon listings, the company's overall gross profit climbed by 8%. Notably, direct-to-consumer revenue saw an impressive increase of 42%, reaching $194,000, thanks to robust sales performance on Amazon and a growing subscriber base. Subscription revenue also rose significantly, up 44% to $56,000.

The company managed to boost its gross margin to a remarkable 68.6%, while its business-to-business (B2B) revenue surged by 57%, indicating strong demand within various professional channels. Although SenesTech reported a net loss of $2.1 million—the result of severance and legal costs—it ended the quarter with $6.8 million in cash, providing a solid foundation for future operations and growth.

Expanding E-Commerce Success

April 2026 marked the first complete month following SenesTech's transition to direct management of its Amazon operations, reflecting a phenomenal increase in e-commerce sales. This month saw sales skyrocketing by 163% to $146,000 compared to the previous year, and an increase of 47% from March 2026. Furthermore, subscription revenue surged by 198% in April, supported by a 109% increase in subscribers, signifying a strong demand for the company’s innovative rodent birth control products.

Strategic Initiatives Under New Leadership

The strategic direction under CEO Michael Edell aims to foster scalable growth while enhancing operational accountability. Previously an Interim COO, Edell emphasized the significance of adapting the direct-to-consumer strategy and refining e-commerce management practices, including a comprehensive redesign of SenesTech's website to improve customer engagement and overall shopping experience.

The company's focus also extends to enhancing its packaging and broadening its B2B outreach, targeting sectors such as pest control, agriculture, and municipal markets, which hold promising revenue potential. Additionally, there’s ongoing momentum in urban deployment initiatives across major cities like Chicago, Boston, and New York, where efforts in municipal rodent contraception pilot programs are already underway.

Future Outlook

Michael Edell articulated a vision for adopting a data-driven business model aimed at establishing sustainable, recurring revenues in response to the growing need for non-toxic pest management solutions. This new strategy seeks to maximize the efficiency of operations and marketing, while reinforcing the company’s commitment to creating healthier environments through its innovative products.

As SenesTech moves further into 2026, the momentum generated from its e-commerce solutions and strategic initiatives under new leadership positions the company for significant growth in the pest control industry, ultimately benefiting its stakeholders and customers alike. With its sights set on operational excellence and market expansion, SenesTech continues to pave the way in the field of humane pest management.

To learn more about SenesTech and its products, visit SenesTech.com.